Kidney Cancer Clinical Trial
Evaluating the Bacterial and Fungal Microbiome in Patients With Calcium Oxalate Urolithiasis and Renal Cell Carcinoma
The purpose of the study is to identify bacterial and fungal microbiome associated with calcium oxalate (CO) urolithiasis and renal cell carcinoma (RCC).
Adults that are able to consent (≥ 18 years of age)
No history of asymptomatic bacteriuria or Urinary Tract Infection within the past 1 month
No history of coagulopathy and not on anticoagulant or antiplatelet medication at the time of surgery.
For patients with urolithiasis, must not have a history of RCC
For patients with RCC, must not have a history of urolithiasis
Controls must have no history of stones, RCC, or urinary tract infection (within 1 month).
For all participants, no antimicrobial treatment within the past month
Adults unable to consent
For patients with urolithiasis, technical difficulty in taking renal papillae biopsy.
History of urinary tract infection within the past 1 month
History of coagulopathy and on anticoagulants or antiplatelets that could not be stopped perioperatively.
Patients with nephrolithiasis and renal tumors with positive preoperative urine cultures- suggesting asymptomatic bacteriuria.
For patients with urolithiasis, a history of RCC
For patients with RCC, a history of urolithiasis
Controls who have a history of stones, RCC, or urinary tract infection.
For all participants, antimicrobial treatment within the past month.
Check Your Eligibility
Let’s see if you might be eligible for this study.
What is your age and gender ?
There is 1 Location for this study
How clear is this clinincal trial information?
Introducing, the Journey Bar
Use this bar to access information about the steps in your cancer journey.